ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1186

Presence of Erosions Is Not a Risk Factor for the Development of Knee OA in a Hand OA Population: The Framingham OA Study

Tine Vanhaverbeke1, Gabriela Rabasa2, Ruth Wittoek1, Ida Kristin Haugen3 and David Felson2, 1Dept. of Rheumatology, Ghent University Hospital, Ghent University, Ghent, Belgium, 2Boston University, Boston, MA, 3Diakonhjemmet Hospital, Oslo, Norway

Meeting: ACR Convergence 2023

Keywords: Epidemiology, hand, Osteoarthritis, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1183–1199) Osteoarthritis – Clinical Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoarthritis (OA) is a prevalent musculoskeletal disease and can affect multiple joint sites in one patient. Studies have shown an association between hand and knee OA (1). However, few studies have examined the association between erosive hand OA, a subtype of hand OA considered to be more inflammatory, and knee OA. The goal of this study was to assess the association between erosive hand OA and knee OA and to identify risk factors for the development of knee OA in a hand OA population.

Methods: All subjects were selected from the Offspring and Community cohorts of the Framingham OA study. Bilateral knee and hand radiographs were obtained and scored using the Kellgren-Lawrence grade (KLG). Radiographic tibiofemoral OA was defined as at least one knee having a KLG≥2. Symptomatic knee OA was defined as presence of radiographic OA, in combination with presence of frequent knee pain. Radiographic hand OA (RHOA) was defined as KLG≥2 in at least one hand joint, erosive hand OA as RHOA plus a central erosion and symptomatic hand OA as RHOA plus pain, aching or stiffness in the same joint. Crude prevalence and incidence numbers were calculated. Multivariable logistic regression analysis, adjusted for age, sex and BMI was performed.

Results: In total, 1293 participants were studied. After adjustment for age, sex and BMI, presence of radiographic hand OA was associated with the development of symptomatic knee OA (OR 1.8 [1.4,2.4]). Similar results were found for symptomatic hand OA as the predictor (OR 1.9 [1.3,2.7]). However, compared with nonerosive hand OA, erosive hand OA was not identified as a risk factor for the development of symptomatic knee OA (OR 1.3 [0.7, 2.6]). Other risk factors identified for the development of symptomatic knee OA were: presence of thumb OA (vs. no thumb OA), presence of OA at a distal interphalangeal (DIP) joint, presence of OA at a proximal interphalangeal (PIP) joint, the number of finger joints affected and a change of at least 1 unit in KL grade in one or more hand joints (interphalangeal and thumb joints). .

Conclusion: This study confirms presence of hand OA is a risk factor for the development of knee OA. However, in a hand OA population, presence of erosions is not an additional risk factor. Our results may suggest that erosive hand OA is unrelated to OA in the knee.

References
< 1. Hirsch R et al. Association of hand and knee osteoarthritis: evidence for a polyarticular disease subset. Ann Rheum Dis. 1996 Jan;55(1):25-9.

Supporting image 1

Supporting image 2


Disclosures: T. Vanhaverbeke: AbbVie, 6; G. Rabasa: None; R. Wittoek: AbbVie, 2, Amgen, 5, Fresenius Kabi, 6, Galapagos, 6, Merck/MSD, 6, Pfizer, 5; I. Haugen: AbbVie/Abbott, 6, GlaxoSmithKlein(GSK), 6, Grünenthal, 6, Novartis, 6, Pfizer, 5; D. Felson: None.

To cite this abstract in AMA style:

Vanhaverbeke T, Rabasa G, Wittoek R, Haugen I, Felson D. Presence of Erosions Is Not a Risk Factor for the Development of Knee OA in a Hand OA Population: The Framingham OA Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/presence-of-erosions-is-not-a-risk-factor-for-the-development-of-knee-oa-in-a-hand-oa-population-the-framingham-oa-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/presence-of-erosions-is-not-a-risk-factor-for-the-development-of-knee-oa-in-a-hand-oa-population-the-framingham-oa-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology